Nvidia's launch of the RTX 50-series has been nothing short of catastrophic and months on, it's not getting any better.

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close. Amicus Therapeutics (FOLD) reported earnings 30 days ago.

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Though there's not been much news directly about the game recently, work on the Star Wars: Knights of the Old Republic (KOTOR) remake is presumed to be ongoing. That said, since we've not seen any ...

AMD's first Radeon RX 9000-series graphics cards, the RX 9070 and RX 9070 XT, will land on March 6 at $549 and $599 MSRPs. They'll feature new RDNA 4 GPU architecture with improved ray tracing and ...

"Call of Duty: Black Ops 6 is an outstanding first-person shooter package that offers a thrilling blockbuster campaign with some of the best graphics ... This old but iconic title has stood ...

After hours: March 21 at 7:13:50 PM EDT Loading Chart for VRTX ...